New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 20, 2018 - The FDA approved Sun Pharma’s Elepsia XR (levetiracetam) extended-release tablets, as adjunctive therapy for the treatment of partial onset seizures in patients 12 years of age and older.
Download PDF
Return to publications
